RxDoctor Payments Data

Ronald Varner, DO

Family Medicine · El Dorado, KSNPI 1578693735

Payments from drug & device makers

$223in general payments, 2019–2025

Across 13 payments — averaging $17.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pfizer$56
  • Amgen$34
  • Corium, LLC$30
  • Abbott$17
  • AstraZeneca$16
  • Lundbeck LLC$16
  • plus $53 from 4 others

What the payments were for

  • Food & beverage$223100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pfizer2$56
Amgen2$34
Corium, LLC2$30
Abbott1$17
AstraZeneca1$16
Lundbeck LLC1$16
Protega Pharmaceutials Inc1$15
Bayer1$14
Phathom Pharmaceuticals, Inc.1$13
AbbVie1$12

How this compares

$223 in reported general payments places this provider in the 35th percentile of 1,469 family medicine providers in Kansas.

See all family medicine providers in Kansas

Medicare billing

Part B allowed, 2024
$173,853
Medicare patients
421
Services billed
3,026

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IngrezzaValbenazine Tosylate13$111,899
EliquisApixaban119$96,947
OzempicSemaglutide60$60,095
JardianceEmpagliflozin85$57,865
MounjaroTirzepatide46$46,938
FarxigaDapagliflozin Propanediol46$37,327
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen1,001$22,255
JanuviaSitagliptin Phosphate39$17,523
Spiriva RespimatTiotropium Bromide32$16,321
Fiasp FlextouchInsulin Aspart (Niacinamide)14$14,782
Novolog FlexpenInsulin Aspart55$13,728
Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog17$12,578
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr18$11,940
TrulicityDulaglutide12$11,797
XareltoRivaroxaban11$11,626

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis, Paxlovid$56$99,805144 claims
AstraZenecaFarxiga, Breztri Aerosphere, Symbicort$16$52,75982 claims
AbbVieSynthroid$12$5,379126 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 35th percentile of 1,469 family medicine providers in Kansas.

Other family medicine in El Dorado

See the full list for Kansas

Where these figures come from

Is this you, or does something look wrong? →